[CAS NO. 2138882-71-8]  KEA1-97

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [2138882-71-8]

Catalog
HY-114982
Brand
MCE
CAS
2138882-71-8

DESCRIPTION [2138882-71-8]

Overview

MDLMFCD31697744
Molecular Weight335.16
Molecular FormulaC15H9Cl2FN4
SMILESClC1=NC(Cl)=NC(NC2=CC=C(C=C2)C3=CC=C(C=C3)F)=N1

For research use only. We do not sell to patients.

Summary

KEA1-97 is a selective Thioredoxin-caspase 3 interaction disruptor ( IC 50 =10 μM). KEA1-97 disrupts the interaction of thioredoxin with caspase 3 , activates caspases, and induces apoptosis without affecting thioredoxin activity [1] .


IC50 & Target

Caspase 3

10 μM (IC 50 )

Thioredoxin

10 μM (IC 50 )


In Vitro

KEA1-97 (100 μM; 231MFP cells) impaires thioredoxin pulldown of caspase 3 [1] .
KEA1-97 (10 μM; 48 hours; 231MFP cells) impaires 231MFP serum-free cell proliferation [1] .
KEA1-97 (10 μM; 0~12 hours; 231MFP cells) activates caspase 3/7 and induces apoptotic cell death [1] .
KEA1-97 (231MFP cells) resistants to survival and proliferation impairments [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis [1]

Cell Line: 231MFP cells
Concentration: 100 μM
Incubation Time:
Result: Impaired thioredoxin pulldown of caspase 3.

Cell Proliferation Assay [1]

Cell Line: 231MFP cells
Concentration: 10 μM
Incubation Time: 48 h
Result: Impaired 231MFP serum-free cell proliferation.

Apoptosis Analysis [1]

Cell Line: 231MFP cells
Concentration: 10 μM
Incubation Time: 0~12 h
Result: Activated caspase 3/7 and induced apoptotic cell death.

In Vivo

KEA1-97 (5 mg/kg; i.p.; 50 days) attenuates tumor xenograft growth [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Immune-deficient SCID mice
Dosage: 5 mg/kg
Administration: I.p.; 50 days
Result: Attenuated tumor xenograft growth.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

4°C, protect from light

* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)


Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL ( 298.36 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.9836 mL 14.9182 mL 29.8365 mL
5 mM 0.5967 mL 2.9836 mL 5.9673 mL
10 mM 0.2984 mL 1.4918 mL 2.9836 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 2.5 mg/mL (7.46 mM); Clear solution

* All of the co-solvents are available by MCE.